Calpain-Mediated Mitochondrial Damage: An Emerging Mechanism Contributing to Cardiac Disease

Mengxiao Zhang1,2,3, Grace Wang4, Tianqing Peng3,5,6

  • 1Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.

Cells
|August 27, 2021
PubMed

Insights

Calpains, calcium-dependent proteases, damage mitochondria in heart disease. Targeting mitochondrial calpain may offer a new therapeutic strategy for cardiac conditions.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Cell Biology

Background:

  • Calpains are calcium-dependent cysteine proteases found in many organisms.
  • Calpain activation is linked to cardiac dysfunction, including cell death, hypertrophy, fibrosis, and inflammation.
  • The precise mechanisms of calpain's role in cardiac disease are not fully understood.

Purpose of the Study:

  • To review the role of calpains in causing mitochondrial damage in cardiac disease.
  • To explore the mechanisms underlying calpain-mediated mitochondrial impairment.
  • To assess the potential of inhibiting mitochondrial calpain as a therapeutic approach for cardiac disease.

Main Methods:

  • Literature review of recent studies on calpains and cardiac disease.
  • Analysis of evidence implicating calpains in mitochondrial dysfunction.
  • Evaluation of therapeutic strategies targeting mitochondrial calpains.

Main Results:

  • Calpains have been identified as key mediators of mitochondrial damage in cardiac disease.
  • Specific mechanisms of calpain-induced mitochondrial injury are being elucidated.
  • Emerging evidence suggests mitochondrial calpain inhibition as a promising therapeutic avenue.

Conclusions:

  • Calpain-mediated mitochondrial damage is a significant factor in cardiac pathology.
  • Further research into these mechanisms can guide the development of novel therapies.
  • Targeting mitochondrial calpains holds potential for treating various cardiac diseases.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.6K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
83
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
915
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
131